Theirs was a small study, and the wide standard deviation in chemerin levels observed in the patients with lung cancer may have potentially obscured their results, as chemerin levels tended to be higher in patients with lung cancer compared to controls. This evidence concerns the gene RARRES2 and lung carcinoma.